Vivoryon Therapeutics NV (FRA:05Y) Ending Cash Position : €9.37 Mil (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Vivoryon Therapeutics NV Ending Cash Position?

Vivoryon Therapeutics NV's Ending Cash Position for the quarter that ended in Dec. 2024 was €9.37 Mil.

Vivoryon Therapeutics NV's quarterly Ending Cash Position declined from Dec. 2023 (€18.56 Mil) to Jun. 2024 (€15.27 Mil) and declined from Jun. 2024 (€15.27 Mil) to Dec. 2024 (€9.37 Mil).

Vivoryon Therapeutics NV's annual Ending Cash Position declined from Dec. 2022 (€26.56 Mil) to Dec. 2023 (€18.56 Mil) and declined from Dec. 2023 (€18.56 Mil) to Dec. 2024 (€9.37 Mil).

Vivoryon Therapeutics NV Ending Cash Position Historical Data

The historical data trend for Vivoryon Therapeutics NV's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivoryon Therapeutics NV Ending Cash Position Chart

Vivoryon Therapeutics NV Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

26.31

14.66

26.56

18.56

9.37

Vivoryon Therapeutics NV Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															26.56	29.58	18.56	15.27	9.37

Vivoryon Therapeutics NV Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Vivoryon Therapeutics NV's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	18.562	+	-9.197
	=	9.37

Vivoryon Therapeutics NV's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	15.272	+	-5.907
	=	9.37

Vivoryon Therapeutics NV Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Vivoryon Therapeutics NV's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Vivoryon Therapeutics NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vivoryon Therapeutics NV (FRA:05Y) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

VVY:Netherlands 0R3M:UK VVYN:Austria

Address

Weinbergweg 22, Halle, SN, DEU, 06120

Website

https://www.vivoryon.com

Vivoryon Therapeutics NV is a Germany-based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products include PQ912 and PQ1565. Geographically, the majority is from Greater China.

Vivoryon Therapeutics NV Headlines

No Headlines